Manulife (Manufacturers Life Insurance)
TVTX icon

Manulife (Manufacturers Life Insurance)’s Travere Therapeutics TVTX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.18M Sell
39,660
-36
-0.1% -$1.08K ﹤0.01% 1748
2025
Q4 		$1.52M Sell
39,696
-4,933
-11% -$160K ﹤0.01% 1649
2025
Q3 		$1.07M Buy
44,629
+527
+1% +$9.91K ﹤0.01% 1822
2025
Q2 		$653K Buy
44,102
+2,613
+6% +$43.3K ﹤0.01% 2040
2025
Q1 		$743K Buy
41,489
+14,151
+52% +$287K ﹤0.01% 1944
2024
Q4 		$476K Sell
27,338
-19,707
-42% -$349K ﹤0.01% 2270
2024
Q3 		$658K Buy
47,045
+17,931
+62% +$187K ﹤0.01% 2134
2024
Q2 		$239K Buy
29,114
+264
+0.9% +$1.78K ﹤0.01% 2525
2024
Q1 		$222K Sell
28,850
-8,352
-22% -$70.5K ﹤0.01% 2547
2023
Q4 		$334K Sell
37,202
-241
-0.6% -$1.75K ﹤0.01% 2356
2023
Q3 		$335K Buy
37,443
+7,924
+27% +$112K ﹤0.01% 2316
2023
Q2 		$453K Buy
29,519
+4,890
+20% +$89K ﹤0.01% 2103
2023
Q1 		$554K Buy
24,629
+169
+0.7% +$3.59K ﹤0.01% 1951
2022
Q4 		$514K Sell
24,460
-519,329
-96% -$11M ﹤0.01% 1971
2022
Q3 		$13.4M Sell
543,789
-504
-0.1% -$13K 0.01% 705
2022
Q2 		$13.2M Buy
544,293
+247
+0% +$6.21K 0.01% 731
2022
Q1 		$14M Sell
544,046
-5,442
-1% -$144K 0.01% 777
2021
Q4 		$16.9K Sell
549,488
-156,437
-22% -$4.41M 0.01% 719
2021
Q3 		$17.1M Sell
705,925
-3,577
-0.5% -$65.7K 0.01% 718
2021
Q2 		$10.4M Sell
709,502
-1,600,385
-69% -$31.6M 0.01% 948
2021
Q1 		$57.7M Buy
2,309,887
+123,057
+6% +$3.4M 0.05% 339
2020
Q4 		$59.6M Sell
2,186,830
-24,311
-1% -$568K 0.06% 307
2020
Q3 		$40.8M Buy
2,211,141
+29,791
+1% +$579K 0.04% 362
2020
Q2 		$43M Sell
2,181,350
-163,067
-7% -$2.6M 0.04% 342
2020
Q1 		$34.2M Buy
2,344,417
+1,685
+0.1% +$25.4K 0.04% 354
2019
Q4 		$33.3M Sell
2,342,732
-979
-0% -$12.5K 0.04% 414
2019
Q3 		$27.8M Buy
2,343,711
+206,908
+10% +$3.42M 0.03% 457
2019
Q2 		$42.9M Buy
2,136,803
+192,515
+10% +$3.8M 0.05% 347
2019
Q1 		$44M Buy
1,944,288
+73,284
+4% +$1.62M 0.05% 340
2018
Q4 		$42.3M Buy
1,871,004
+25,601
+1% +$637K 0.05% 330
2018
Q3 		$53M Buy
1,845,403
+327,194
+22% +$9.35M 0.06% 314
2018
Q2 		$41.4M Buy
1,518,209
+1,488,347
+4,984% +$39.6M 0.05% 394
2018
Q1 		$668K Buy
29,862
+222
+0.7% +$5.29K ﹤0.01% 2118
2017
Q4 		$626K Buy
29,640
+615
+2% +$14.1K ﹤0.01% 2173
2017
Q3 		$723K Sell
29,025
-1,052
-3% -$23.2K ﹤0.01% 2013
2017
Q2 		$583K Buy
30,077
+1,733
+6% +$31.4K ﹤0.01% 2174
2017
Q1 		$524K Buy
28,344
+3,362
+13% +$65.8K ﹤0.01% 2150
2016
Q4 		$473K Sell
24,982
-20
-0.1% -$409 ﹤0.01% 2137
2016
Q3 		$559K Buy
25,002
+49
+0.2% +$933 ﹤0.01% 2010
2016
Q2 		$445K Buy
24,953
+1,794
+8% +$29K ﹤0.01% 2113
2016
Q1 		$310K Buy
23,159
+192
+0.8% +$2.91K ﹤0.01% 2292
2015
Q4 		$443 Buy
22,967
+245
+1% +$4.89K ﹤0.01% 2089
2015
Q3 		$460 Buy
22,722
+560
+3% +$16.6K ﹤0.01% 2053
2015
Q2 		$735 Buy
22,162
+7,721
+53% +$211K ﹤0.01% 1862
2015
Q1 		$346 Sell
14,441
-27
-0.2% -$412 ﹤0.01% 2326
2014
Q4 		$177 Buy
14,468
+365
+3% +$3.78K ﹤0.01% 2727
2014
Q3 		$127 Buy
14,103
+460
+3% +$5.41K ﹤0.01% 2961
2014
Q2 		$160K Buy
+13,643
New +$185K ﹤0.01% 2893

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s TVTX Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Travere Therapeutics (TVTX) stake by 0.09% in Q1 2026, selling an estimated $1.08K and leaving 39,660 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #1748.

Manulife (Manufacturers Life Insurance) first reported a position in TVTX in Q2 2014 and has held it in 48 quarters since. The position peaked at $59.6M in Q4 2020. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 39,660 shares of Travere Therapeutics worth $1.18M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 36 Travere Therapeutics shares in Q1 2026, an estimated $1.08K.
  • Travere Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1748 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Travere Therapeutics in Q2 2014 and has held it in 48 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Travere Therapeutics position peaked at $59.6M in Q4 2020.
  • 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.